Fitbit, Dexcom to Develop Continuous Glucose Monitoring (CGM) Experience

MHW learned Thursday that Fitbit — a leading global wearables brand — and DexCom, Inc. — a leader in continuous glucose monitoring (CGM) for people with diabetes — have cemented a new collaboration to develop and market products to help people better manage their diabetes and get a more complete picture of their overall health with easy-to-use mobile tools.

The first planned initiative is to bring Dexcom CGM data to Fitbit’s new smartwatch, Fitbit Ionic.

Through this experience, Dexcom CGM users on either Android or iOS devices would be able to see both activity and glucose levels, right on their wrist.

“The strength of our brand and our ability to track critical health metrics continuously for up to 4+ days[1], coupled with Dexcom’s market leadership in CGM, present a powerful combination that we hope will help millions of people better manage their diabetes,” said James Park, CEO of Fitbit. “With Ionic, we are focused on driving positive health outcomes and more health focused tools, and this collaboration is a wonderful example of how we plan to bring that vision to our users.”

More details about the partnership are expected in the coming days.

This post was written by:

- who has written 2051 posts on mHealthWatch.


Contact the author

0 comments
Advert